NCT04775823 is a NA clinical trial of Hybrid composite nano-ceramic in Dental Wear, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT04775823?

NCT04775823 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT04775823?

Interventions in NCT04775823: Hybrid composite nano-ceramic.

What condition does NCT04775823 study?

NCT04775823 studies Dental Wear.

Is NCT04775823 still recruiting?

NCT04775823 is currently status unknown. Last updated 4 March 2021.

Last reviewed 2021-03-04 · How we verify

NCT04775823

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hybrid Ceramic on Worn Dentition Patients

Status unknown NA Last updated 4 March 2021

What this trial tests

NA trial testing Hybrid composite nano-ceramic in Dental Wear in 50 participants. Status unknown.

Timeline

2 March 2021

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	2 March 2021
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Taiwan

Drugs / interventions tested

Hybrid composite nano-ceramic

Conditions studied

Dental Wear — all drugs for Dental Wear →

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 100, any sex, with Dental Wear. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of hybrid composite-nanoceramic on material characteristic and clinical use over tooth wear patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04775823 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 4 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04775823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing